Koninklijke Philips | PHG - Cash And Equivalent



Koninklijke Philips reported EUR1.82B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Abbott USD 6.95B 419M Jun/2025
Baxter International USD 2.29B 530M Mar/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Boston Scientific USD 725M 311M Mar/2025
Danaher USD 2.96B 964M Jun/2025
Demant 1.14B 30M Jun/2025
Dexcom USD 1.16B 254.1M Jun/2025
Edwards Lifesciences USD 3.14B 95.4M Mar/2025
Fresenius EUR 1.23B 1.16B Jun/2025
General Electric Aerospace USD 10.86B 1.54B Jun/2025
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 229.45M 231.82M Jun/2025
GN Store Nord DKK 787M 99M Mar/2025
Hitachi JPY 866.24B 143.04B Mar/2025
Hologic USD 1.74B 305.7M Jun/2025
Idexx Laboratories USD 164.59M 624K Jun/2025
Insulet USD 1.12B 107M Jun/2025
Integra LifeSciences USD 217.91M 21.19M Jun/2025
Intuitive Surgical USD 9.53B 431.3M Jun/2025
J&J USD 38.47B 32.35B Mar/2025
Koninklijke Philips EUR 1.82B 579M Jun/2025
Masimo USD 149.6M 18.8M Jun/2025
Medtronic USD 2.22B 978M Apr/2025
Philips EUR 1.82B 629M Jun/2025
ResMed USD 1.21B 276.74M Jun/2025
Steris USD 279.7M 108M Jun/2025
Stryker USD 2.38B 55M Jun/2025
Teleflex USD 253.7M 30.42M Jun/2025
Terumo JPY 204.29B 17.58B Jun/2025
Zimmer Biomet Holdings USD 556.9M 827.6M Jun/2025